Agreement Strengthens European Foothold Amidst Growing Demand

WEB IMC Scales in Germany with Glasshouse Botanics Supply Deal

Agreement Strengthens European Foothold Amidst Growing Demand

Toronto, Ontario--(Newsfile Corp. - January 17, 2023) - WEB Investment Management Corp. (CSE: WIMC) ("WEB IMC" or the "Company"), an international cannabis company providing premium cannabis products to medical patients in Israel and Germany, today announced that its wholly-owned subsidiary, WEB IMCC Israel Medical Cannabis Corp. ("WEB IMCC"), has entered into a new supply agreement with Glasshouse Botanics ("Glasshouse"), an EU-GMP certified glasshouse cultivator based in Germany. This agreement represents a significant step in WEB IMC's growth strategy in Germany, a key market for the Company's premium medical cannabis products.

Accelerated Growth in Germany

The German medical cannabis market is experiencing significant growth, driven by increasing patient demand and government support. WEB IMC, as a leading medical cannabis provider in Israel, is well-positioned to capitalize on this growing opportunity through its established distribution network and strong relationships with healthcare professionals in Germany.

The supply agreement with Glasshouse Botanics will enable WEB IMC to meet the growing demand for its premium medical cannabis products in Germany. Glasshouse Botanics, a reputable cultivator with EU-GMP certification, will supply WEB IMC with high-quality, indoor-grown medical cannabis, ensuring a consistent and reliable supply for patients in Germany.

"This is a strategic agreement that will significantly enhance our ability to meet the growing demand for our products in Germany," said Miki Zadeh, CEO of WEB IMC. "Glasshouse Botanics is a highly respected cultivator with EU-GMP certification, and we are confident that their high-quality products will be well-received by patients in Germany."

The agreement is expected to contribute to WEB IMC's accelerated growth in Germany. The Company is committed to providing patients with access to the highest quality medical cannabis products and continues to explore opportunities to expand its presence in key international markets.